SYK and colorectal carcinoma: Our studies emphasize a novel molecular mechanism by which C. tropicalis potentiates the immunosuppressive function of MDSCs and suggest that Syk-PKM2-HIF-1α-glycolysis axis may be a potential therapeutic target for CRC.